Summary of The Do-Nothing Dilemma

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

The Do-Nothing Dilemma summary
Start getting smarter:
or see our plans

Rating

8 Overall

9 Applicability

8 Innovation

7 Style


Recommendation

Journalist Charlotte Huff makes a good case for “watchful waiting” in low-risk cancers and precancerous conditions. Highly sensitive scans pick up on changes so early today that it can be unclear what they will become: There can be false positives, and some cancers are extremely slow-growing. Unexpectedly, Huff makes it equally clear why some patients’ medical decision-making process means they are better off having surgery and peace of mind than living with uncertainty. While never giving medical advice, getAbstract recommends these thoughtful insights to readers interested in the risks, benefits and emotional implications of watchful waiting.

In this summary, you will learn

  • How technology is contributing to early detection of cancerous changes,
  • Why it is sometimes best to watch and wait, and
  • Why some patients find “watchful waiting” easier than others.
 

About the Author

Charlotte Huff is a Texas-based journalist, political science major and Fulbright journalism scholar. Her features have appeared in American Way, Genome, Medical Economics, Slate and Women’s Health.

 

Summary

Thanks to advances in scans and other medical testing technology, doctors can detect “suspicious” cellular changes earlier than ever before. It’s not always clear whether these changes will become harmful in the patient’s lifetime. Medical experts are learning that it’s better not to treat slow-moving...

More on this topic

Customers who read this summary also read

Immune System, Unleashed by Cancer Therapies, Can Attack Organs
Immune System, Unleashed by Cancer Therapies, Can Attack Organs
9
A Radically Simple Idea Will Let Us Catch Cancer Before It’s Cancer
A Radically Simple Idea Will Let Us Catch Cancer Before It’s Cancer
8
Cancer Pill Costs Soar as Drug Companies Retain Pricing Power
Cancer Pill Costs Soar as Drug Companies Retain Pricing Power
8
The Lucky Years
The Lucky Years
8
When Evidence Says No, but Doctors Say Yes
When Evidence Says No, but Doctors Say Yes
8
The Death of Patient Zero
The Death of Patient Zero
7

Related Channels

Comment on this summary